Lymphoma: Treatment Warning Signs
During chemotherapy, radiation, and other treatment regimens, there are certain side effects that should be reported to your doctor immediately. These side effects might indicate an adverse reaction to medicine or an underlying health problem that requires medical attention.
This list is by no means complete; it is intended as a starting point. See the "Resources" at the bottom of the page for more information.
If you experience any of the following, alert your doctor:
- A fever, usually over 100.5°F (38°C)
- Unusual fatigue
- Any infection
- Prolonged constipation or diarrhea
- Blood in the stool or urine
- Mouth or throat sores
- Excessive cough
- Shortness of breath
- Dizziness
- Unexpected weight gain or loss (10 pounds / 4 kilos or more)
- Swelling in the legs
- Tingling in your fingers or toes
- Ringing in your ears
- Red dots under your skin
- Unusual bruising or bleeding
- Nausea or vomiting despite medication
- Chest pain
- Palpitations
- Wheezing
- Intense Chills
- Pain or soreness at the chemo injection site or catheter site
Your doctor may provide you with a more extensive list of symptoms than this. If so, listen to your doctor. Don’t expect to experience all of the symptoms on this list, as side effects differ from patient to patient. What you experience depends on your body’s individual reaction to treatment.
Do ask your medical team any questions you have, and ask what to do before treatment. Have medical contact information (telephone numbers, etc.) readily available in case of emergency.
Dive Deeper
Related Articles
- Non-Hodgkin's Lymphoma: Chemotherapy
- Non-Hodgkin's Lymphoma: Treatment
- Non-Hodgkin's Lymphoma: Resources
- Bone Marrow and Stem Cell Transplants
- Non-Hodgkin's Lymphoma: Diagnosis
- Lymphoma Classification and Types
- Non-Hodgkin's Lymphoma: Aggressive NHLs
- Non-Hodgkin's Lymphoma: Indolent NHLs
- Non-Hodgkin's Lymphoma: Introduction
- Secondary Cancer
- Peripheral Neuropathy
Resources
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
